Brain and Spinal Cord Tumors in Adults: Prognostic Factors

For most types of cancer, the stage of the cancer -- a measure of how far it has spread -- is one of the most important factors in selecting treatment options and in determining a person's outlook (prognosis).

But tumors of the brain and spinal cord differ in some important ways from cancers in other parts of the body. One of the main reasons other cancers are dangerous is that they can spread throughout the body. Tumors starting in the brain or spinal cord can spread to other parts of the central nervous system, but they almost never spread to other organs. These tumors are dangerous because they can interfere with essential brain functions.

Because tumors in the brain or spinal cord almost never spread to other parts of the body, they do not have a formal staging system like most other cancers. Some of the important factors that help determine a person’s outlook include:

  • Their age
  • Their functional level (whether the tumor is affecting normal brain functions and everyday activity)
  • The type of tumor (such as astrocytoma, ependymoma, etc.)
  • The grade of the tumor (how quickly the tumor is likely to grow, based on how the cells look under a microscope)
  • If the tumor cells have certain gene mutations or other changes (For example, tumors with a mutation in the IDH1 or IDH2 gene, known as “IDH-mutant” tumors, tend to grow more slowly and have a better outlook than tumors without these mutations.)
  • The location and size of the tumor
  • How much of the tumor can be removed by surgery (if it can be done)
  • Whether or not the tumor has spread through the cerebrospinal fluid to other parts of the brain or spinal cord
  • Whether or not tumor cells have spread beyond the central nervous system

If you have a brain or spinal cord tumor, talk to your doctor to learn more about how these and other factors might affect your outlook and treatment options.

The American Cancer Society medical and editorial content team
Our team is made up of doctors and master’s-prepared nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.

Chang SM, Mehta MP, Vogelbaum MA, Taylor MD, Ahluwalia MS. Chapter 97: Neoplasms of the central nervous system. In: DeVita VT, Lawrence TS, Rosenberg SA, eds. DeVita, Hellman, and Rosenberg’s Cancer: Principles and Practice of Oncology. 10th ed. Philadelphia, Pa: Lippincott Williams & Wilkins; 2015.

Dorsey JF, Hollander AB, Alonso-Basanta M, et al. Chapter 66: Cancer of the central nervous system. In: Abeloff MD, Armitage JO, Niederhuber JE. Kastan MB, McKenna WG, eds. Abeloff’s Clinical Oncology. 5th ed. Philadelphia, Pa: Elsevier; 2014.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Central Nervous System Cancers. V.1.2017. Accessed at www.nccn.org/professionals/physician_gls/pdf/cns.pdf on September 14, 2017.

Last Medical Review: September 30, 2017 Last Revised: November 6, 2017

American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.